Rationales, evidence, and design considerations for fractionated radioimmunotherapy

This publication has 53 references indexed in Scilit:

• Apoptosis-Related Gene and Protein Expression in Human Lymphoma Xenografts (Raji) After Low Dose Rate Radiation Using ⁶⁷Cu-2IT-BAT-Lym-1 Radioimmunotherapy
  Cancer Biotherapy & Radiopharmaceuticals, 2001
• Confirmation of improved local-regional control with altered fractionation in head and neck cancer
  International Journal of Radiation Oncology*Biology*Physics, 2000
• A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003
  Published by Elsevier ,2000
• Low-dose, Fractionated Radioimmunotherapy for B-cell Malignancies using¹³¹I-LYM-1 Antibody
  Cancer Biotherapy & Radiopharmaceuticals, 1998
• Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas
  The Lancet, 1995
• Overview of animal studies comparing radioimmunotherapy with dose equivalent external beam irradiation
  Radiotherapy and Oncology, 1992
• The dose-rate effect revisited: Radiobiological considerations of importance in radiotherapy
  International Journal of Radiation Oncology*Biology*Physics, 1991
• Radiobiological comparison of external beam irradiation and radioimmunotherapy in renal cell carcinoma xenografts
  International Journal of Radiation Oncology*Biology*Physics, 1989
• Radiation biology
  Cancer, 1985
• The Steepness of the Dose—Response Curve in Radiation Therapy
  Radiology, 1975